Cargando…
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
BACKGROUND: In multidrug regimens, including an intravenous aminoglycoside (e.g. amikacin [AMK]) is recommended for difficult-to-treat non-tuberculous mycobacterial (NTM) lung diseases. We aimed to evaluate the efficacy, safety, and feasibility of inhaled AMK therapy in patients with difficult-to-tr...
Autores principales: | Yagi, Kazuma, Ishii, Makoto, Namkoong, Ho, Asami, Takahiro, Iketani, Osamu, Asakura, Takanori, Suzuki, Shoji, Sugiura, Hiroaki, Yamada, Yoshitake, Nishimura, Tomoyasu, Fujiwara, Hiroshi, Funatsu, Yohei, Uwamino, Yoshifumi, Kamo, Tetsuro, Tasaka, Sadatomo, Betsuyaku, Tomoko, Hasegawa, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550988/ https://www.ncbi.nlm.nih.gov/pubmed/28793869 http://dx.doi.org/10.1186/s12879-017-2665-5 |
Ejemplares similares
-
Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients
por: Asakura, Takanori, et al.
Publicado: (2015) -
Theory and strategy for Pneumococcal vaccines in the elderly
por: Namkoong, Ho, et al.
Publicado: (2015) -
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
por: Namkoong, Ho, et al.
Publicado: (2016) -
Pulmonary nocardiosis caused by Nocardia cyriacigeorgica in patients with Mycobacterium aviumcomplex lung disease: two case reports
por: Yagi, Kazuma, et al.
Publicado: (2014) -
Levels of Soluble Receptor for Advanced Glycation End Products in Bronchoalveolar Lavage Fluid in Patients with Various Inflammatory Lung Diseases
por: Kamo, Tetsuro, et al.
Publicado: (2016)